CIK 0000315545
- Non-accelerated filer
- Smaller reporting company
PROVECTUS BIOPHARMACEUTICALS, INC.
Sign in to watch- Ticker
- PVCT
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 900031917
- Phone
- +1 866-594-5999
- Business address
- 800 S. GAY STREET, SUITE 1610, KNOXVILLE, TN, 37929
- Former names
- PROVECTUS PHARMACEUTICALS INC, PROVECTUS PHARMACEUTICAL INC, ZAMAGE DIGITAL IMAGING INC, SPM GROUP INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-02 | Raines Heather CFO | Grant or award · Stock Options (Right to Buy) | +4,197,890 | 4,197,890 | ||
| 2024-02-28 | Raines Heather CFO | Returned to the company · 8% Unsecured Convertible Promissory Note due 2022 | −0 | $50,000.00 | $0 | |
| 2024-02-02 | Raines Heather CFO | Returned to the company · 8% Unsecured Convertible Promissory Note due 2022 | −0 | $25,000.00 | $0 | |
| 2021-08-16 | Raines Heather CFO | Grant or award · 8% Unsecured Convertible Promissory Note due 2022 | +0 | $200,000.00 | $0 | |
| 2021-06-20 | Raines Heather CFO | Exercise or conversion · 8% Secured Convertible Promissory Notes due 2021 | −0 | 0 | ||
| 2021-06-20 | Raines Heather CFO | Exercise or conversion · Series D-1 Convertible Preferred Stock | +20,289 | 20,289 | ||
| 2021-06-17 | Raines Heather CFO | Grant or award · 8% Secured Convertible Promissory Notes due 2021 | +0 | |||
| 2020-11-10 | Raines Heather CFO | Grant or award | +50,000 | 1,213,153 | ||
| 2019-03-25 | Raines Heather Chief Financial Officer | Grant or award | +50,000 | 1,163,153 |
Page 1 of 1 · 9 trades